Novel Anti Double-Stranded Nucleic Acids Full-Length Recombinant Camelid Heavy-Chain Antibody for the Detection of miRNA

The discovery that certain diseases have specific miRNA signatures which correspond to disease progression opens a new biomarker category. The detection of these small non-coding RNAs is performed routinely using body fluids or tissues with real-time PCR, next-generation sequencing, or amplification...

Descripción completa

Detalles Bibliográficos
Autores principales: Czarnecka, Malgorzata, Weichelt, Ulrike, Rödiger, Stefan, Hanack, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181593/
https://www.ncbi.nlm.nih.gov/pubmed/35682952
http://dx.doi.org/10.3390/ijms23116275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181593/
https://www.ncbi.nlm.nih.gov/pubmed/35682952
http://dx.doi.org/10.3390/ijms23116275

Ejemplares similares